Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results

    NEXT STORY
    Amarin Highlights Key REDUCE-IT®-Related Data Presented at American Heart Association 2019 Scientific Sessions
    PREV STORY
    Amarin’s John Thero Awarded EY Entrepreneur of The Year® 2019 Life Sciences National Award
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioRestorative Therapies Granted Key Metabolic Patent

    MELVILLE, N.Y., Nov. 19, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the ...

    author_avatar
    NASDAQ Market News

    Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT

    SUNNYVALE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical ...

    author_avatar
    NASDAQ Market News

    Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update

    author_avatar
    NASDAQ Market News